Regulations.gov document
Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and…
Supporting & Related Material · FDA-2011-N-0003 · posted Jan 27, 2012
Key facts
| Document ID | FDA-2011-N-0003-0072 |
|---|---|
| Title | Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel |
| Document type | Supporting & Related Material |
| Subtype | Reference (internal unless indicated) |
| Agency | FDA |
| Docket | FDA-2011-N-0003 |
| Posted | Jan 27, 2012 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: